AXSOME THERAPEUTICS, INC. Accounts Payable
AXSOME THERAPEUTICS, INC. (AXSM) had Accounts Payable of $78.97 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-10
- 2026-06-30: Accounts Payable, Current $78.97M.
- 2026-03-31: Accounts Payable, Current $106.70M.
- 2025-12-31: Accounts Payable, Current $65.54M.
- 2025-09-30: Accounts Payable, Current $54.23M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $78.97M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $106.70M 10-Q · filed 2026-05-04 | |
| 2025-12-31 | $65.54M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $54.23M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $91.63M 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $85.66M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $72.00M 10-K · filed 2026-02-23 | |
| 2024-09-30 | $64.25M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $61.34M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $53.79M 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $40.68M 10-K · filed 2025-02-18 | |
| 2023-09-30 | $29.10M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $42.96M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $35.77M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $38.60M 10-K · filed 2024-02-23 | $38.61M 10-K · filed 2023-02-28 |
| 2022-09-30 | $12.84M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $19.43M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $12.60M 10-Q · filed 2022-05-02 | |
| 2021-12-31 | $13.15M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $13.38M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $11.61M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $14.62M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $13.50M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $11.32M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $9.36M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $12.19M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $10.94M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $9.45M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $6.14M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $3.43M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $3.69M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $4.17M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $3.18M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $3.87M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $3.44M 10-K · filed 2019-03-15 | |
| 2017-09-30 | $2.94M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $4.04M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $4.74M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $4.08M 10-K · filed 2018-03-07 | |
| 2016-09-30 | $3.87M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $3.04M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $1.83M 10-Q/A · filed 2016-08-09 | |
| 2015-12-31 | $1.89M 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |